1,196 results on '"Feldman, Andrew L."'
Search Results
2. Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
3. Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning
4. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders
5. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)
6. Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
7. Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era
8. Lymphomatoid Papulosis With T-cell Receptor–Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis
9. Breast Implant Associated Anaplastic Large Cell Lymphoma: Evidence-Based Consensus Conference Statement From The American Association of Plastic Surgeons
10. Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature
11. Molecular and clinicopathological features of granzyme B-negative extranodal NK/T-cell lymphoma
12. Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation
13. Extranodal T- and NK-cell lymphomas
14. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities
15. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas
16. Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
17. Current Concepts in Nodal Peripheral T-Cell Lymphomas
18. Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
19. Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association
20. Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis
21. Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma
22. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
23. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
24. Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
25. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up
26. American Association of Plastic Surgeons Consensus on Breast Implant--Associated Anaplastic Large-Cell Lymphoma.
27. Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
28. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL)
29. Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship
30. Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia
31. Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis
32. Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair
33. American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms
34. Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
35. The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma
36. Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
37. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
38. Corrigendum to “Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.” [Modern Pathology 34 (2021) 2154–2167]
39. Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma
40. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
41. Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract
42. Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma
43. Charged black rings in supergravity with a single non-zero gauge field
44. Motive and opportunity: MYCrearrangements in high-grade B-cell lymphoma with MYCand BCL2rearrangements (an LLMPP study)
45. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
46. Spinal Meningeal Mass Lesion: A Rare Presentation of Primary Dural Follicular Lymphoma.
47. The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
48. Molecular and clinicopathological features of granzyme B-negative extranodal NK/T-cell lymphoma
49. TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
50. Spinal Meningeal Mass Lesion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.